Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3641-3645

  Jeong, Jeongmi K ^a,c   Wogan, Gerald N ^a   Lau, Serrine S ^b   Monks, Terrence J ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE DERIVATIVE; HYDROQUINONE DERIVATIVE; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL LINE; CYTOTOXICITY; DELETION MUTANT; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; MUTAGENICITY; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PLASMID; PRIORITY JOURNAL;

BASE SEQUENCE; CELL LINE; DNA; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; ESCHERICHIA COLI; FLAVONOIDS; GENES, SUPPRESSOR; GLUTATHIONE; HUMANS; HYDROQUINONES; KIDNEY; MOLECULAR SEQUENCE DATA; MUTAGENS; PHENOLS; POINT MUTATION; POLYMERS; REACTIVE OXYGEN SPECIES; RNA, TRANSFER;

EID: 0033178703     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ames, B. N. Endogenous DNA damage as related to cancer and aging. Mutat. Res., 214: 41-46, 1989.
2. Leadon, S. A., Stampfer, M. R., and Hartley, J. Production of oxidative DNA damage during the metabolic activation of benzo[a]pyrene in human mammary epithelial cells correlates with cell killing. Proc. Natl. Acad. Sci. USA, 85: 4365-4368, 1988.
3. Ames, B. N., and Gold, L. S. Endogenous mutagens and the causes of aging and cancer. Mutat. Res., 250: 3-16, 1991.
4. Epe, B. Genotoxicity of singlet oxygen. Chem. Biol. Interact., 80: 239-260, 1991.
5. Weitzman, S. A., and Stossel, T. P. Mutation caused by human phagocytes. Science (Washington DC), 212: 546-547, 1981.
6. Wiseman, H., and Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. (1996) Biochem. J., 313: 17-29.
7. Weitberg, A. B., Weitzman, S. A., Destrempes, M., Latt, S. A., and Stossel, T. P. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N. Engl. J. Med., 308: 26-29, 1983.
8. Breimer, L. H. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinog., 3: 188-197, 1990.
9. Floyd, R. A. The role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J., 4: 2587-2597, 1990.
10. Loft, S., and Poulsen, H. E. Cancer risk and oxidative DNA damage in man. J. Mol. Med., 74: 297-312, 1997.
11. Wang, D., Kreutzer, D. A., and Essigman, J. M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res., 400: 99-115, 1998.
12. Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachoski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., and Walborg, E. F., Jr. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect., 106 (Suppl. 1): 289-295, 1998.
13. Emerit, I., and Cerutti, D. A. Tumour promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action. Nature (Lond.), 293: 144-146, 1981.
14. Wits, G., Goldstein, B. D., Amoruso, M., Stone, D. S., and Troll, W. Retinoid inhibition of superoxide anion radical production by human polymorphonuclear leukocytes stimulated with tumor promoters. Biochem. Biophys. Res. Commun., 97: 883-888, 1980.
15. Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., and Graham, D. G. Contemporary issue in toxicology: quinone chemistry and toxicity. Toxicol. Appl. Pharmacol., 112: 2-16, 1992.
16. Ames, B. N. Dietary carcinogens and anticarcinogens. Science (Washington DC), 221: 1256-1264, 1993.
17. Chesis, P. L., Levin, D. E., Smith, M. T., Ernester, L., and Ames, B. N. Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA, 81: 1696-1700, 1984.
18. Morimoto, K., Wolff, S., and Koizumi, A. Induction of sister-chromatid exchanges in human lymphocytes by microsomal activation of benzene metabolites. Mutat. Res., 119: 355-360, 1983.
19. Rinsky, R. A., Young, R. J., and Smith, A. B. Leukemia in benzene workers. Am. J. Ind. Med., 2: 217-245, 1981.
20. Shibata, M., Hirose, M., Tanaka, H., Askawa, E., Ahirai, T., and Ito, N. Induction of renal cell tumors in rats and mice and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn. J. Cancer Res., 82: 1211-1219, 1991.
21. Kari, F. W., Bucher, J., Eustis, S. L., Haseman, J. K., and Huff, J. E. Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem. Toxicol., 30: 737-747, 1992.
22. Eastmond, D. A., Smith, M. T., and Irons, R. D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol., 91: 85-95, 1987.
23. Smith, M. T., Evans, C. G., Thor, H., and Orrenius, S. Quinone-induced oxidative injury to cells and tissues. In: H. Sies (ed.), Oxidative Stress, pp. 91-113. London: Academic Press, 1985.
24. O'Brien, P. J. Molecular mechanism of quinone cytotoxicity. Chem. Biol. Interact., 80: 1-41, 1991.
25. Monks, T. J., and Lau, S. S. Biological reactivity of polyphenolic-glutathione conjugates. Chem. Res. Toxicol. 10: 1296-1313, 1997.
26. Monks, T. J., and Lau, S. S. The pharmacology and toxicology of polyphenolic-glutathione conjugates. Annu. Rev. Pharmacol. Toxicol., 38: 229-255, 1998.
27. Wefers, H., and Sies, H. Hepatic low-level chemiluminescence during redox cycling of menadione and the menadione-glutathione conjugate: relation to glutathione and NAD(P)H: quinone reductase (DT-diaphorase) activity. Arch. Biochem. Biophys., 224: 568-578, 1983.
28. Brown, P. C., Dulik, D. M., and Jones, T. W. The toxicity of menadione (2-methyl-1,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells. Arch. Biochem. Biophys., 285: 187-196, 1991.
29. Lau, S. S., Peters, M. M., Kleiner, H. E., Canales, P. L., and Monks, T. J. Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity Adv. Exp. Med. Biol., 387: 267-273, 1996.
30. Peters, M. M., Lau, S. S., Dulik, D. M., Murphy, D., van Ommen, B., van Bladeren, P. J., and Monks, T. J. Metabolism of 2-tert-butylhydroquinone to S-substituted conjugates in the male Fischer 344 rat. Chem. Res. Toxicol., 9: 133-139, 1996.
31. Hill, B. A., Kleiner, H. E., Ryan, E. A., Dulik, D. M., Monks, T. J., and Lau, S. S. Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy. Chem. Res. Toxicol., 6: 459-469, 1993.
32. Lau, S. S., Hill, B. A., Highet, R. J., and Monks, T. J. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol., 34: 829-836, 1988.
33. Peters, M. M., Jones, T. W., Monks, T. J., and Lau, S. S. Cytotoxicity and cell proliferation induced by the nephrocarcinogen hydroquinone, and its nephrotoxic metabolite 2,3,5-tris-(glutathion-S-yl)hydroquinone. Carcinogenesis (Lond.), 18: 2393-2401, 1997.
34. Peters, M. M., Jones, T. W., Monks, T. J., and Lau, S. S. Glutathione conjugates of 2-tert-butylhydroquinone, metabolites of the renal tumor promoter tert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer Res., 56: 1006-1011, 1996.
35. Butterworth, M., Lau, S. S., and Monks, T. J. Metabolism and mild nephrotoxicity of 17β-estradiol in the golden Syrian hamster. Formation of catechol estrogen glutathione conjugates and implications for 17β-estradiol-mediated nephrocarcinogenicity. Carcinogenesis (Lond.), 18: 561-567, 1997.
36. Butterworth, M., Lau, S. S., and Monks, T. J. 2-Hydroxy-4-glutathion-S-yl-17β-estradiol and 2-hydroxy-1-glutathion-S-yl-17β-estradiol produce oxidative stress and renal toxicity in an animal model of hormone-mediated nephrocarcinogenicity. Carcinogenesis (Lond.), 19: 133-139, 1998.
37. Juedes, M. J., and Wogan, G. N. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res. 349: 51-61, 1996.
38. Moraes, E. C., Keyes, S. M., Pidoux, M., and Tyrrell, R. M. The spectrum of mutations generated by passage of a hydrogen peroxide damaged shuttle vector plasmid through a mammalian host. Nucleic Acids Res., 17: 8301-8312, 1989.
39. Jeong, J. K., Juedes, M. J., and Wogan, G. N. Mutations induced in the supF gene of pSP189 by hydroxyl radical and singlet oxygen: relevance to peroxynitrite mutagenesis. Chem. Res. Toxicol., 11: 550-556, 1998.
40. Merterns, J. J. W. M., Gibson, N. W., Lau, S. S., and Monks, T. J. Reactive oxygen species and DNA damage in 2-bromo-(glutathion-S-yl)hydroquinone mediated cytotoxicity. Arch. Biochem, Biophys., 320: 51-58, 1995.
41. Jeong, J. K., Dybing, E., Søderlund, E., Brunborg, G., Holme, J. A., Lau, S. S., and Monks, T. J. DNA damage, gadd153 expression, and cytotoxicity in plateau-phase renal proximal tubular epithelial cells treated with a quinol thioether. Arch. Biochem. Biophys., 341: 300-308, 1997.
42. Jeong, J. K., Stevens, J. L., Lau, S. S., and Monks, T. J. Quinone-thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells. Mol. Pharmacol., 50: 592-598, 1996.
43. Akman, S. A., Forrest, G. P., Doroshow J. H., and Dizdaroglu, M. Mutation of potassium permanganate- and hydrogen peroxide-treated plasmid pZ189 replicating in CV-1 monkey kidney cells. Mutat. Res. 261: 123-130, 1991.
44. Waters, L. C., Sikpi, M. O., Preston, R. J., Mitra, S., and Jaberaaboansari, A. Mutations induced by ionizing radiation in a plasmid replicated in human cells. Radiat. Res., 127: 190-201, 1991.
45. Keyes, S. M., Amaudruz, F., and Tyrrell, R. M. Determination of the spectrum of mutations induced by defined-wavelength solar UVB (313 nm) radiation in mammalian cells by use of a shuttle vector. Mol. Cell. Biol., 8: 5425-5431, 1988.
46. Sikpi, M. O., Freeman, M. L., Ziobron, E. R., Upholt, W. B., and Lurie, A. G. Dependence of the mutation spectrum in a shuttle plasmid replicated in human lymphoblasts on dose of gamma radiation. Int. J. Radiat. Biol., 59: 1115-1126, 1991.
47. Florin, J. Rutberg, L., Curvall, M., and Enzell, C. R. Screening of tobacco smoke constituents for mutagenicity using the Ames' test. Toxicology, 18: 219-232, 1980.
48. Sakai, M., Yoshida, D., and Mizusaki, S. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97. Mutat. Res., 156: 61-67, 1985.
49. Gocke, E., Wild, D., Eckhardt, K., and King, M. T. Mutagenicity studies with the mouse spot test. Mutat. Res., 117: 201-212, 1983.
50. Gocke, E., King, M-T., Eckhardt, K., and Wild, D. Mutagenicity of cosmetics ingredients licensed by the European Communities. Mutat. Res., 90: 91-109, 1981.
51. Hakura, A., Tsutsui, Y., Mochida, H., Sugihara, Y., Mikami, T., and Sagami, F. Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains. Mutat. Res. 371: 293-299, 1996.
52. Hakura, A., Mochida, H., Tsutsui, Y., and Yamatsu, K. Mutagenicity of benzoquinones for Ames Salmonella tester strains. Mutat. Res., 347: 37-43, 1995.
53. Joseph, P., and Jaiswal, A. K. NAD(P)H quinone oxidoreductase I reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones. Br. J. Cancer, 77: 709-719, 1998.
54. Retèl, J., Hoebee, B., Braun, J. E. F., Lutgerink, J. T., van den Akker, E., Wanamarta, A. H., Joenje, H, and Lafleur, M. V. V. M. Mutational specificity of oxidative DNA damage. Mutat. Res., 299: 165-182, 1993.
55. McBride, T. J., Schneider, J. E., Floyd, R. A., and Loeb, L. A. Mutations induced by methylene blue plus light in single-stranded M13mp2. Proc. Natl. Acad. Sci. USA, 89: 6866-6870, 1992.
56. Reid, T. M., Feig, D. I., and Loeb, L. A. Mutagenesis by metal-induced oxygen radicals. Environ. Health Perspect., 102 (Suppl. 3): 57-61, 1994.